Clinical Trials Browser

Unknown × OTHER_GOV × Trastuzumab × Clear all

NCT03947242 2019-05-15

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.

Phase NA Unknown

HER2 Positive Breast Cancer